Thus, ARID2 mutations interrupting its C2H2 domain could not recruit DNMT1 to the SNAIL promoter, resulting in reduced methylation of its promoter, linked to vascular metastasis and poor prognosis in HCC patients [153]. This evidence concerns the gene ARID2 and hepatocellular carcinoma.